Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUSD659020 S1
Publication typeGrant
Application numberUS 29/404,541
Publication dateMay 8, 2012
Filing dateOct 21, 2011
Priority dateNov 13, 2009
Also published asUSD650295, USD658990, USD658991, USD658992, USD659016, USD659017, USD659018, USD659019, USD659021, USD659022
Publication number29404541, 404541, US D659020 S1, US D659020S1, US-S1-D659020, USD659020 S1, USD659020S1
InventorsStefan Kemner
Original AssigneeAvidiamed Gmbh
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Blister pack for pharmaceuticals
US D659020 S1
Abstract  available in
Images(11)
Previous page
Next page
Claims(1)
  1. The ornamental design for a blister pack for pharmaceuticals, as shown and described.
Description

FIG. 1 is a front-left-top perspective view of a blister pack for pharmaceuticals according to a first embodiment of the present invention;

FIG. 2 is a view from the top side thereof;

FIG. 3 is a view from the bottom side thereof;

FIG. 4 is a view from the left side thereof;

FIG. 5 is a view from the right side thereof;

FIG. 6 is a view from the front side thereof;

FIG. 7 is a view from the rear side thereof;

FIG. 8 is a front-left-top perspective view of a blister pack for pharmaceuticals according to a second embodiment of the present invention;

FIG. 9 is a view from the top side thereof;

FIG. 10 is a view from the bottom side thereof;

FIG. 11 is a view from the left side thereof;

FIG. 12 is a view from the right side thereof;

FIG. 13 is a view from the front side thereof; and,

FIG. 14 is a view from the rear side thereof.

Although the design is illustrated as transparent, the claimed invention may also be embodied as opaque.

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US9339615Mar 14, 2013May 17, 2016Mannkind CorporationDry powder inhaler and system for drug delivery
US9346766Apr 30, 2014May 24, 2016Mannkind CorporationCatalysis of diketopiperazine synthesis
US9364436Jun 18, 2012Jun 14, 2016Mannkind CorporationHigh capacity diketopiperazine microparticles and methods
US9446001Jun 22, 2015Sep 20, 2016Mannkind CorporationIncreasing drug affinity for crystalline microparticle surfaces
US9446133Oct 21, 2014Sep 20, 2016Mannkind CorporationDry powder inhaler and system for drug delivery
US9511198Nov 27, 2013Dec 6, 2016Mannkind CorporationDry powder inhaler and system for drug delivery
US9610351Feb 13, 2015Apr 4, 2017Mannkind CorporationMethods and compositions for treating pain
US9630930Apr 11, 2014Apr 25, 2017Mannkind CorporationDiketopiperazine microparticles with defined specific surface areas
US9655850Nov 18, 2015May 23, 2017Mannkind CorporationSubstituted diketopiperazine analogs for use as drug delivery agents
US9662461May 2, 2016May 30, 2017Mannkind CorporationDry powder drug delivery system and methods
US9675674Jan 8, 2016Jun 13, 2017Mannkind CorporationDiketopiperazine salts for drug delivery and related methods
US9700690Jun 12, 2014Jul 11, 2017Mannkind CorporationInhalation apparatus
US9706944Mar 24, 2015Jul 18, 2017Mannkind CorporationApparatus and method for simulating inhalation efforts
US9717689Feb 5, 2016Aug 1, 2017Mannkind CorporationMethod of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9796688Apr 12, 2016Oct 24, 2017Mannkind CorporationCatalysis of diketopiperazine synthesis
US9801925Mar 5, 2015Oct 31, 2017Mannkind CorporationPotentiation of glucose elimination
US9802012Jul 12, 2013Oct 31, 2017Mannkind CorporationDry powder drug delivery system and methods
Classifications
U.S. ClassificationD09/732